Here's today's Facebook post from Berkley Bio: "GoldNApel

New Post Public Reply Private Reply Replies (2) Message Board
LegalGirl
Here's today's Facebook post from Berkley Bio:

"
GoldNApel 10/13/13

Three anecdotes from Dr. Apel

Last X-mas Eve two big bikers carried my daughter-in-law into my home. She had been told by her doctors to just go home and die. She had stage 4 cancer and had already gone through her insurance and the doctors had exhausted their arsenal of treatments. She was weak, gaunt and pale from the cancer and the brutal chemo and radiation therapies that she had endured. She only came to us because she wanted my wife, the mother of the father of her children and grandchildren, to promise to look after her offspring after her death. I just happened to have some “Simpson” medicine that Dave had given to me for inspection. She already had her paperwork together so I immediately started her on the therapy. Two days later she walked unaided to her car. Two weeks after that she went back to the hospital and was told that her cancer was now stage 2. She celebrated the news by doing her first solo parachute jump. Yes, she did pull the cord. She is now in complete remission.

Such a success story has to be put in context. In her 50’s, she had grown up in the Haight and in Sonoma County as a child and had considerable exposure to recreational drugs of all kinds, in some cases to the point of abuse. With her whole family involved in growing pot in Sonoma/Lake counties she had been smoking a lot her whole life. She had no problem at all with getting so stoned on the therapy. In fact, she enjoyed it! And continues to. All my grandchildren look to me like Jesus because I saved their mom. I guess I was in the right place with the right drug at the right time. But things don’t always work out so cleanly.

About a month later I got a call from a very old friend. He had heard about my involvement with medical marijuana and wanted my advice. He had mobility problems and some other chronic conditions and thought maybe our therapy could help. It took him a few weeks but he finally got his paperwork together and so my wife and I gave him a house call. We took an assortment of goodies, but the main one was Dave’s whole plant extract. As we were leaving I mentioned that he must respect that the extract is very strong and gets you very stoned. Pace yourself till you find out your comfort level.

He laughed at me and scoffed. “Who do you think you’re talking to? Get too stoned? I was in Vietnam and then with you in the Haight. I’ve been smoking weed for 50 years and I don’t even know why I do it cause it doesn’t even seem to get me high anymore.” 48 hours later I called him to see how things were going. He said “What in the hell did you do to me? I couldn’t walk for 12 hours and even then, the search for the bathroom in my studio apartment seemed like a climb up Everest.” This is when I first realized there was a potential problem with our therapy. Mr. G is doing fine now that he has found his effective dosage and claims that the extract has “reset” his biologic processes. (That doesn’t sound very scientific, does it? Oh well, that’s the way these anecdotes go.)

One more story: This one with a different ending. I got a call from one of my oldest friends about a lady who lived in the cottage behind his house. She had stage 4 ovarian cancer. His old house in Mill Valley was first a hunting lodge before the bridge was built, then a whorehouse, then the first Grateful Dead office (Round Records) in the 60’s and early 70’s. I have always been fascinated by that little cottage back there and always dreamed about living there myself. My wife and I, along with Dave and his wife Mary Ann (that’s the two founders of Dharma and me, constituting three of the four partners of B-Bio) stopped by her home to drop off her medicine and give her support. I had never met her before, but I realized right away she was completely inexperienced with recreational drugs. She was a legal consultant in the financial district and had never smoked pot. But god only knows what prescription drugs she was on. Two days later she called and informed us that she had stopped our therapy because she could not tolerate the side effects. I can just imagine how terrified she must have been, as well as living under the stress of cancer. Two weeks later she was dead.

Dave challenged me with the task of figuring out how to help such patients by providing a medicine that was an effective treatment, but non psychoactive. If we would have had Dharmanol at that time, this lady might well be still alive.

We did it! And the hits just keep on coming. We have had substantial success in the lab recently in this regard and new products/innovations will be revealed soon. I can say no more. Dave Gold and I would like you all to know: Should you or a loved one get sick and need our help we will be there for you, and if you can’t pay for the treatment, we will cover it."

That last line brought tears to my eyes.  My son and I had a discussion just this morning about who he should get in touch with if I ever get sick.  Way to go GoldNApel.

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Automotive Key Blank Market Insights for Smart Keys Growth

Updated Category News Views 97

The Expanding Landscape of the Automotive Key Blank Market The automotive key blank market is experiencing a transformative phase, poised to grow from USD 6.29 billion in 2025 to an impressive USD 9.67 billion by 2034. This remarkable growth reflects the industry’s ongoing adaptation to technological advancements, particularly the rising adoption of smart and automated...

Continue Reading
Innovations Drive Growth in the Meat Processing Equipment Sector

Updated Category News Views 231

Insights into the Expanding Meat Processing Equipment Market The global meat processing equipment market is anticipated to experience significant growth, projected to reach USD 16.36 billion by 2032. This remarkable increase from its value of USD 11.25 billion in 2024 represents a robust compounded annual growth rate (CAGR) of 4.86% from 2025 to 2032. The factors driving...

Continue Reading
Fed's Waller Advocates Rate Cuts in December Amid Labor Weakness

Updated Category News Views 173

Fed's Waller Emphasizes Importance of Rate Cuts Christopher Waller, a Governor at the Federal Reserve, has spoken out about the economic challenges facing the labor market. He is advocating for a reduction in the Fed’s policy rate during the next meeting, scheduled for December. His approach centers on the need to address the risks associated with a weakening labor...

Continue Reading
GIA-L Expands Innovation and Leadership with New Chapter Launch

Updated Category News Views 270

Global Initiative on Ageing and Longevity Launches U.S. Chapter The Global Initiative on Ageing and Longevity (GIA-L) has propelled its mission forward by launching a North American Chapter. This initiative is designed to accelerate innovation and foster significant business growth while addressing the changing demographics and needs of an aging population. The GIA-L...

Continue Reading
Deadline Alert: Faruqi & Faruqi's Investigation for Investors

Updated Category News Views 47

Investigating Extreme Networks: What You Need to Know Faruqi & Faruqi, LLP, a well-known national securities law firm, is currently looking into possible claims on behalf of investors in Extreme Networks, Inc. (NASDAQ: EXTR). The firm is reaching out to investors who have incurred losses exceeding $100,000 to discuss their options and legal rights. With the situation...

Continue Reading